CSat Investment Advisory’s Nu Skin NUS Stock Holding History

CSat Investment Advisory’s Portfolio NUS Stock Details NUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-135	Closed	-$3K	–	1149
2020 Q1	$3K	Buy	135 +32	+31%	+$963	﹤0.01%	1054
2019 Q4	$4K	Buy	103 +12	+13%	+$490	﹤0.01%	1070
2019 Q3	$4K	Buy	91 +12	+15%	+$503	﹤0.01%	1055
2019 Q2	$4K	Buy	+79	New	+$4.02K	﹤0.01%	1063

Other funds holding NUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

CSat Investment Advisory's NUS Position: Q2 2020 in Review

CSat Investment Advisory sold out of Nu Skin (NUS) in Q2 2020, closing a stake of 135 shares — an estimated $3K sold.

CSat Investment Advisory first reported a position in NUS in Q2 2019 and held it in 4 quarters. The position peaked at $4K in Q4 2019. 226 funds tracked by Wall St. Rank hold NUS as of Q2 2020.

CSat Investment Advisory reported no remaining Nu Skin position as of Q2 2020 after selling out during the quarter.
CSat Investment Advisory sold 135 Nu Skin shares in Q2 2020, an estimated $3K.
CSat Investment Advisory first reported a position in Nu Skin in Q2 2019 and held it in 4 quarters.
CSat Investment Advisory's Nu Skin position peaked at $4K in Q4 2019.
226 funds tracked by Wall St. Rank held Nu Skin as of Q2 2020.

Based on CSat Investment Advisory's 13F filing for Q2 2020, filed 7 Aug 2020.